
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $799.2M | -- | -- | -- | -- |
07/31/2025 | Q2 | $792.1M | -- | -- | -- | -- |
05/08/2025 | Q1 | $802.6M | $712.4M | $0.35 | -- | -- |
02/28/2025 | Q4 | $722.1M | $612.9M | $0.20 | -- | -- |
11/07/2024 | Q3 | $748.4M | $785.3M | $0.38 | -- | -- |
08/01/2024 | Q2 | $748M | $748.3M | $0.37 | -- | -- |
05/01/2024 | Q1 | $771.3M | $829.9M | $0.42 | -- | -- |
03/12/2024 | Q4 | $785.4M | $670.9M | $0.37 | -- | -- |
09/30/2023 | Q3 | -- | -- | $0.32 | -- | -- |
06/30/2023 | Q2 | -- | -- | $0.33 | -- | -- |
03/31/2023 | Q1 | -- | -- | $0.30 | -- | -- |
12/31/2022 | Q4 | -- | -- | $0.49 | -- | -- |
09/30/2022 | Q3 | -- | -- | $0.15 | -- | -- |
06/30/2022 | Q2 | -- | -- | $0.21 | -- | -- |
03/31/2022 | Q1 | -- | -- | $0.44 | -- | -- |
12/31/2021 | Q4 | -- | -- | $0.13 | -- | -- |
09/30/2021 | Q3 | -- | -- | $0.25 | -- | -- |
06/30/2021 | Q2 | -- | -- | $0.02 | -- | -- |
03/31/2021 | Q1 | -- | -- | $0.74 | -- | -- |
12/31/2020 | Q4 | -- | -- | -$0.55 | -- | -- |
09/30/2020 | Q3 | -- | -- | $0.13 | -- | -- |
06/30/2020 | Q2 | -- | -- | $0.07 | -- | -- |
03/31/2020 | Q1 | -- | -- | $0.36 | -- | -- |
12/31/2019 | Q4 | -- | -- | -$0.76 | -- | -- |
09/30/2019 | Q3 | -- | -- | $0.18 | -- | -- |
06/30/2019 | Q2 | -- | -- | $0.24 | -- | -- |
03/31/2019 | Q1 | -- | -- | $0.05 | -- | -- |
12/31/2018 | Q4 | -- | -- | -$0.15 | -- | -- |
09/30/2018 | Q3 | -- | -- | $0.02 | -- | -- |
06/30/2018 | Q2 | -- | -- | -$0.02 | -- | -- |
03/31/2018 | Q1 | -- | -- | $0.05 | -- | -- |
12/31/2017 | Q4 | -- | -- | -$0.34 | -- | -- |
09/30/2017 | Q3 | -- | -- | -$0.05 | -- | -- |
06/30/2017 | Q2 | -- | -- | -$0.22 | -- | -- |
03/31/2017 | Q1 | -- | -- | $0.02 | -- | -- |
12/31/2016 | Q4 | -- | -- | -$0.11 | -- | -- |
09/30/2016 | Q3 | -- | -- | $0.02 | -- | -- |
06/30/2016 | Q2 | -- | -- | -$3.73 | -- | -- |
03/31/2016 | Q1 | -- | -- | $0.11 | -- | -- |
12/31/2015 | Q4 | -- | -- | -$1.11 | -- | -- |
09/30/2015 | Q3 | -- | -- | -$19.00 | -- | -- |
National Bank of Greece SA reported $712.4M worth of top line sales in its most recent quarter.
National Bank of Greece SA announced earnings per share of $0.35 which represents a beat of analyst forecast a -- per share.
National Bank of Greece SA reported -- that represents -- per share over the last quarter.
National Bank of Greece SA's earnings are forecast to grow from $1.37 per share to -- per share next year representing an increase of --.
National Bank of Greece SA's next earnings date is July 31, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.